UK markets close in 6 hours 40 minutes

Hyloris Pharmaceuticals SA (HYL.BR)

Brussels - Brussels Delayed price. Currency in EUR
Add to watchlist
15.35+0.10 (+0.66%)
As of 10:17AM CET. Market open.
Currency in EUR

Valuation measures

Market cap (intra-day) 5388.78M
Enterprise value 3335.43M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)424.21
Price/book (mrq)7.74
Enterprise value/revenue 3360.29
Enterprise value/EBITDA 7-31.97

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 352.50%
S&P500 52-week change 326.87%
52-week high 317.20
52-week low 39.26
50-day moving average 314.70
200-day moving average 313.61

Share statistics

Avg vol (3-month) 39.32k
Avg vol (10-day) 39.52k
Shares outstanding 525.83M
Implied shares outstanding 6N/A
Float 813.39M
% held by insiders 156.19%
% held by institutions 13.48%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)30 Jun 2021


Profit margin 0.00%
Operating margin (ttm)-378.95%

Management effectiveness

Return on assets (ttm)-3.25%
Return on equity (ttm)-21.03%

Income statement

Revenue (ttm)931k
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)2,105.30%
Gross profit (ttm)30k
Net income avi to common (ttm)-11.64M
Diluted EPS (ttm)-0.46
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)53.48M
Total cash per share (mrq)2.08
Total debt (mrq)11.85M
Total debt/equity (mrq)23.19
Current ratio (mrq)21.77
Book value per share (mrq)1.98

Cash flow statement

Operating cash flow (ttm)-13.95M
Levered free cash flow (ttm)-7.3M